Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.

Oncotarget · 2015 · PMC4484484 · PMID 25860928

Europe PMC DOI

hedged sentence

0.1070

closest p · 2.1× alpha

0.1070

boldest claim

The sentences

showed a trendp = 0.107not close (p > 0.1)

CXCR4 expression significantly increased at recurrence ( p = 0.029), and expression of its ligand CXCL12 showed a trend toward an increase ( p = 0.107).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.